VEGF receptor signalling ? in control of vascular function
The DOI matches its Crossref record; 140 of the 141 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Vascular endothelial growth-factor receptors (VEGFRs) regulate the cardiovascular system. VEGFR1 is required for the recruitment of haematopoietic precursors and migration of monocytes and macrophages, whereas VEGFR2 and VEGFR3 are essential for the functions of vascular endothelial and lymphendothelial cells, respectively. Recent insights have shed light onto VEGFR signal transduction and the interplay between different VEGFRs and VEGF co-receptors in development, adult physiology and disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These proteins collectively contribute to promoting angiogenic activities by influencing endothelial cell proliferation [49,53,54].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [54]
In the citing paper
“Moreover, EVs’ content also encompasses an array of growth factors such as soluble growth factors like VEGF, TGFB1, IL-8, and HGF.”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [54]
In the citing paper
“Additionally, miRNAs cargos in MSCs EVs such as miR210, miR126, miR132, and miR21 have been identified as contributors to angiogenesis [49,54].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [54]
In the citing paper
“Flt-1 is one of the main receptors of the vascular endothelial growth factor (VEGF) family widely expressed in the vascular system.33”
From CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease (2018) · cites this paper as [33]
Citations
Cites
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,117 · cited 1×
“Inactivation of a single Vegfa allele in mice results in early lethality at embryonic day (E)11?12 owing to deficient endothelial-cell development and lack of vessel”
BackgroundTumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,972
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X.-F., Breitman, M. L., & Schuh, A. C. (1995) · Nature · doi:10.1038/376062a0 · Cited by 3,931
Circulating angiogenic factors and the risk of preeclampsia
Levine, R. J., Maynard, S. E., Qian, C., Lim, K.-H., England, L. J., Yu, K. F., Schisterman, E. F., Thadhani, R., Sachs, B. P., Epstein, F. H., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031884 · Cited by 3,720
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,628 · cited 1×
“Inactivation of a single Vegfa allele in mice results in early lethality at embryonic day (E)11?12 owing to deficient endothelial-cell development and lack of vessel”
BackgroundVEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Circulating angiogenic factors and the risk of preeclampsia*
(2004) · Obstetrics & Gynecology · doi:10.1097/00006250-200405000-00028 · Cited by 2,615
Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
Fulton, D., Gratton, J.-P., McCabe, T. J., Fontana, J., Fujio, Y., Walsh, K., Franke, T. F., Papapetropoulos, A., & Sessa, W. C. (1999) · Nature · doi:10.1038/21218 · Cited by 2,608
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
Fong, G.-H., Rossant, J., Gertsenstein, M., & Breitman, M. L. (1995) · Nature · doi:10.1038/376066a0 · Cited by 2,606
Cited by
Items 301–400 of 1,013
Fu, Z., Chen, X., Guan, S., Yan, Y., Lin, H., & Hua, Z. (2015) · Oncotarget · doi:10.18632/oncotarget.3625 · Cited by 132
“VEGF, as a mitogen and survival factor for vascular endothelial cells, is a crucial regulator of vascular development during embryogenesis as well as bloodvessel formation in the adult [1].”
BackgroundDalrymple, N. A., & Mackow, E. R. (2011) · Journal of Virology · doi:10.1128/jvi.05008-11 · Cited by 142
“Endothelial cells respond to and elicit a myriad of cellular, platelet-associated, and secreted factors that affect vascular permeability (10, 22, 52, 56, 57, 63, 73, 82, 83).”
BackgroundTyrosine kinase signaling in fibrotic disorders
Beyer, C., & Distler, J. H. W. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.06.008 · Cited by 126
“variants of VEGF-A can further fine tune VEGF signaling [31].”
BackgroundZhang, Q., Gou, W., Wang, X., Zhang, Y., Ma, J., Zhang, H., Zhang, H., & Zhang, H. (2016) · Genome Biology and Evolution · doi:10.1093/gbe/evw032 · Cited by 147
Nazer, B., Humphreys, B. D., & Moslehi, J. J. (2011) · Circulation · doi:10.1161/circulationaha.110.992230 · Cited by 127
Oguro, Y., Miyamoto, N., Okada, K., Takagi, T., Iwata, H., Awazu, Y., Miki, H., Hori, A., Kamiyama, K., & Imamura, S. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.08.017 · Cited by 126
Goyal, A., Pal, N., Concannon, M., Paul, M., Doran, M., Poluzzi, C., Sekiguchi, K., Whitelock, J. M., Neill, T., & Iozzo, R. V. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.243626 · Cited by 116
Assis, L., Moretti, A. I. S., Abrahão, T. B., de Souza, H. P., Hamblin, M. R., & Parizotto, N. A. (2012) · Lasers in Medical Science · doi:10.1007/s10103-012-1183-3 · Cited by 127
“This process is regulated by vascular endothelial growth factor (VEGF) that exerts multiple effects on the vascular endothelium including stimulation of endothelial cell proliferation, rapid induction of microvascular permeability, promotion of endothelial cell survival, stimulation of endothelial cell adhesion and mi…”
BackgroundDevelopmental and pathological angiogenesis in the central nervous system
Vallon, M., Chang, J., Zhang, H., & Kuo, C. J. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1625-0 · Cited by 124
“Activation of veGFR2 in endothelial cells activates several signaling pathways such as the MAP kinase and PI3 kinase/Akt pathways mediating migration, proliferation, and survival [43].”
Amburgey, Ö. A., Chapman, A. C., May, V., Bernstein, I. M., & Cipolla, M. J. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.158931 · Cited by 137
Adam, A. P., Sharenko, A. L., Pumiglia, K., & Vincent, P. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.079277 · Cited by 125
The Role of Macrophages in the Infarcted Myocardium: Orchestrators of ECM Remodeling
O’Rourke, S. A., Dunne, A., & Monaghan, M. G. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00101 · Cited by 143
“Such signals arise, for example, during development and regulation and include the release of vascular endothelial growth factor (VEGF) which activates endothelial cells to initiate angiogenesis (7), or in response to trauma or injury, where signaling is mediated by pro-inflammatory cytokines such as tumor necrosis fa…”
BackgroundKappers, M. H. W., de Beer, V. J., Zhou, Z., Danser, A. H. J., Sleijfer, S., Duncker, D. J., van den Meiracker, A. H., & Merkus, D. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.182220 · Cited by 130
The Molecular Basis of VEGFR-1 Signal Transduction Pathways in Primary Human Monocytes
Tchaikovski, V., Fellbrich, G., & Waltenberger, J. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.158022 · Cited by 116
Yamazaki, Y., Matsunaga, Y., Tokunaga, Y., Obayashi, S., Saito, M., & Morita, T. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809071200 · Cited by 123
Li, X., Wu, L., Liu, W., Jin, Y., Chen, Q., Wang, L., Fan, X., Li, Z., & Cheng, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095004 · Cited by 137
Elkaeed, E. B., Yousef, R. G., Elkady, H., Gobaara, I. M. M., Alsfouk, B. A. A., Husein, D. Z., Ibrahim, I. M., Metwaly, A. M., & Eissa, I. H. (2022) · Molecules · doi:10.3390/molecules27144606 · Cited by 124
“The vascular endothelial growth factor (VEGF) pathway is an important regulator of the angiogenesis process and led to the discovery of a wide array of chemotherapeutic agents [5,6].”
Backgroundten Dam, G. B., van de Westerlo, E. M. A., Purushothaman, A., Stan, R. V., Bulten, J., Sweep, F. C. G. J., Massuger, L. F. A. G., Sugahara, K., & Kuppevelt, T. H. V. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070111 · Cited by 127
Jiang, L., Luan, Y., Miao, X., Sun, C., Li, K., Huang, Z., Xu, D., Zhang, M., Kong, F., & Li, N. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.214 · Cited by 133
“Of note, both VEGFR-2 signalling and a9b1 outside-in signalling operated through PI3K–PKC–MAPK pathway (Moreno-Layseca and Streuli, 2014; Olsson et al, 2006).”
BackgroundSidibe, A., Ropraz, P., Jemelin, S., Emre, Y., Poittevin, M., Pocard, M., Bradfield, P. F., & Imhof, B. A. (2018) · Nature Communications · doi:10.1038/s41467-017-02610-0 · Cited by 117
The RTK Interactome: Overview and Perspective on RTK Heterointeractions
Paul, M. D., & Hristova, K. A. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00467 · Cited by 127
Endothelialization of arterial vascular grafts by circulating monocytes
Smith, R. J., Nasiri, B., Kann, J., Yergeau, D. A., Bard, J., Swartz, D. D., & Andreadis, S. T. (2020) · Nature Communications · doi:10.1038/s41467-020-15361-2 · Cited by 121
Verhaar, E. R., Woodham, A. W., & Ploegh, H. L. (2020) · Seminars in Immunology · doi:10.1016/j.smim.2020.101425 · Cited by 133
Langenkamp, E., & Molema, G. (2009) · Cell and Tissue Research · doi:10.1007/s00441-008-0642-4 · Cited by 119
“Moreover, the adaptor molecule Shb binds to phosphorylated Tyr1175, thereby activating phosphatidylinositol-3 kinase, which in turn activates the serine/threonine kinase AKT/protein kinase B pathway that mediates survival of the endothelial cells (Olsson et al. 2006).”
BackgroundThe Role of Vascular Endothelial Growth Factor in Metastatic Prostate Cancer to the Skeleton
Wanicek, E., Cossigny, D. A. F., & Quan, G. M. Y. (2013) · Prostate Cancer · doi:10.1155/2013/418340 · Cited by 121
Genetic association with response to intravitreal ranibizumab in patients with neovascular AMD
Kloeckener-Gruissem, B., Barthelmes, D., Labs, S., Schindler, C., Kurz-Levin, M., Michels, S., Fleischhauer, J., Berger, W., Sutter, F., & Menghini, M. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6080 · Cited by 120
“One of the most important seems to be the production of vascular endothelial growth factor (VEGF).(1,2) Intravitreal injection of the anti-vascular endothelial growth factor (anti-VEGF) compounds, ranibizumab (Lucentis; Novartis, Basel, Switzerland; and Genentech Inc.”
BackgroundKim, Y. R., Kim, H. N., Ahn, S., Choi, Y. H., Shin, H. K., & Choi, B. T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090000 · Cited by 126
Endothelial Response to Glucocorticoids in Inflammatory Diseases
Zielińska, K. A., Moortel, L. V., Opdenakker, G., Bosscher, K. D., & den Steen, P. E. V. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00592 · Cited by 131
“In mammals, five VEGF ligands (VEGF-A, -B, -C, -D, and placental growth factor—PLGF) can bind to three receptor tyrosine kinases—VEFG receptor-1, -2, and -3 (32).”
BackgroundSchweighofer, B., Testori, J., Sturtzel, C., Sattler, S., Mayer, H., Wagner, O., Bilban, M., & Hofer, E. (2009) · Thrombosis and Haemostasis · doi:10.1160/th08-12-0830 · Cited by 114
“These include receptor dimerization and phosphorylation of the cytoplasmic domain on tyrosine residues, which serve as docking sites for downstream signal transducers (10, 11).”
BackgroundKang, D. H., Lee, D. J., Lee, K. W., Park, Y. S., Lee, J. Y., Lee, S., Koh, Y. J., Koh, G.-Y., Choi, C., Yu, D., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.040 · Cited by 127
Reynolds, A. R. (2010) · Dose-Response · doi:10.2203/dose-response.09-049.reynolds · Cited by 132
“…therapy, either by directly incorporating into the vasculature or by secreting factors that promote endothelial or tumor cell survival (Rafii et al. 2002; Orimo et al. 2005; Bertolini et al. 2006; De Palma and Naldini 2006; Murdoch et al. 2008; Shojaei and Ferrara 2008; Crawford et al. 2009).”
BackgroundVEGF Promotes Proliferation of Human Glioblastoma Multiforme Stem‐Like Cells through VEGF Receptor 2
Xu, C., Wu, X., & Zhu, J. (2013) · The Scientific World Journal · doi:10.1155/2013/417413 · Cited by 116
“The function of VEGFR1 is to modulate VEGFR2 signaling; also VEGFR1may act as a decoy receptor, sequestering VEGF from VEGFR2 binding [17, 18].”
BackgroundJain, A., Saxena, S., Khanna, V. K., Shukla, R. K., & Meyer, C. H. (2013) · PubMed Central · Cited by 137
Park, J., Kim, M., Sun, K., An, Y. A., Gu, X., & Scherer, P. E. (2017) · Diabetes · doi:10.2337/db16-1081 · Cited by 113
“Vascular endothelial growth factor (VEGF)-A is classically known to be involved in vascular development during embryogenesis (vasculogenesis), as well as blood vessel formation (angiogenesis) and tissue remodeling in the adult organism (3).”
Zhang, H., Zhang, Y., Cheng, Y., Gong, F., Cao, Z., Yu, L., & Guo, X. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22718 · Cited by 127
“VEGFR-2 is theprimary receptorofVEGF in itsproangiogenicactivity.(37)PI3K/Akt/NF-κBpathway can regulate the invasion of carcinoma cells, featured with the upregulationofVEGF, suggesting thecritical roleofVEGFas thedownstream target of PI3K/Akt/NF-κB in mediating cancer invasion and metastasis.”
BackgroundSmits, M., Mir, S. E., Nilsson, R. J. A., van der Stoop, P. M., Niers, J. M., Marquez, V. E., Cloos, J., Breakefield, X. O., Krichevsky, A. M., Noske, D. P., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016282 · Cited by 118
“and VEGFR2 thereby causing endothelial cell survival, proliferation, and sprouting [7].”
BackgroundHansen, T. M., Moss, A., & Brindle, N. P. J. (2008) · Current Neurovascular Research · doi:10.2174/156720208786413433 · Cited by 125
p53 promotes VEGF expression and angiogenesis in the absence of an intact p21-Rb pathway
Ghahremani, M. F., Goossens, S., Nittner, D., Bisteau, X., Bartunkova, S., Zwolińska, A., Hulpiau, P., Haigh, K., Haenebalcke, L., Drogat, B., et al. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.12 · Cited by 119
“It stimulates endothelial cell survival, mitogenesis and cell migration in vitro, and is essential for the generation of new blood vessels during embryonic development and in the adult after injury.(1) Furthermore, high VEGF”
BackgroundBehdani, M., Zeinali, S., Khanahmad, H., Karimipour, M., Asadzadeh, N., Azadmanesh, K., Khabiri, A., Schoonooghe, S., Habibi‐Anbouhi, M., Hassanzadeh‐Ghassabeh, G., et al. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.11.013 · Cited by 118
Heckman, C. A., Holopainen, T., Wirzenius, M., Keskitalo, S., Jeltsch, M., Ylä‐Herttuala, S., Wedge, S. R., Jürgensmeier, J. M., & Alitalo, K. K. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5809 · Cited by 117
Bougatef, F., Quemener, C., Kellouche, S., Naïmi, B., Podgorniak, M.-P., Millot, G., Gabison, E. E., Calvo, F. M., Dosquet, C., Lebbé, C., et al. (2009) · Blood · doi:10.1182/blood-2009-04-217380 · Cited by 128
Servin, A. L. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-14 · Cited by 143
“, the vascular development that occurs during embryogenesis, and the angiogenesis process that forms blood vessels (474).”
BackgroundVEGFA links self-renewal and metastasis by inducing Sox2 to repress miR-452, driving Slug
Kim, M., Jang, K., Miller, P., Picon‐Ruiz, M., Yeasky, T. M., El‐Ashry, D., & Slingerland, J. M. (2017) · Oncogene · doi:10.1038/onc.2017.4 · Cited by 118
Ji, B., Cai, H., Yang, Y., Peng, F., Song, M., Sun, K., Yan, F., & Liu, Y. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.04.046 · Cited by 119
Crafts, T. D., Jensen, A. R., Blocher-Smith, E. C., & Markel, T. A. (2014) · Cytokine · doi:10.1016/j.cyto.2014.08.005 · Cited by 118
Functional and pharmacological characterization of a VEGF mimetic peptide on reparative angiogenesis
Finetti, F., Basile, A. M., Capasso, D., Gaetano, S. D., Stasi, R. D., Pascale, M. C., Turco, M. C., Ziche, M., Morbidelli, L., & D’Andrea, L. D. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.04.011 · Cited by 116
“Whereas the role of VEGFR-1 is still under debate, it is well known that VEGFR-2 phosphorylation stimulates ECs proliferation, migration and survival [4–6].”
BackgroundReversibility of endothelial dysfunction in diabetes: role of polyphenols
Suganya, N., Bhakkiyalakshmi, E., Sarada, D. V. L., & Ramkumar, K. M. (2016) · British Journal of Nutrition · doi:10.1017/s0007114516001884 · Cited by 113
“Provoked ER stress increases the activity of JNK and catalytic IκB kinase subunits and induces inflammation associated with impairment of insulin receptor substrate 1 (IRS-1) signalling, thus linking diabetes and vascular endothelial dysfunction((12,76)).”
Basagiannis, D., Zografou, S., Murphy, C., Fotsis, T., Morbidelli, L., Ziche, M., Bleck, C., Mercer, J., & Christoforidis, S. (2016) · Journal of Cell Science · doi:10.1242/jcs.188219 · Cited by 116
“The isoform of VEGF used throughout the present study is VEGF165a, the most well studied ligand of VEGFR2 (Olsson et al., 2006), thereafter called simply VEGF.”
BackgroundMethodInfluentialMicroRNAs as pharmacological targets in endothelial cell function and dysfunction
Chamorro-Jorganes, A., Araldi, E., & Suárez, Y. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.04.002 · Cited by 122
“[122] Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L.”
de Oliveira, R. L., Hamm, A., & Mazzone, M. (2011) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.04.001 · Cited by 133
Shaik, F., Cuthbert, G. A., Homer‐Vanniasinkam, S., Muench, S. P., Ponnambalam, S., & Harrison, M. A. (2020) · Biomolecules · doi:10.3390/biom10121673 · Cited by 131
“In most metazoan species, genes encoding VEGF-A, VEGF-B, VEGF-C, VEGF-D and placental growth factor (PIGF) are present [12,13].”
BackgroundInfluentialEbos, J. M. L., Lee, C. R., Bogdanovic, E., Alami, J., Van Slyke, P., Francia, G., Xu, P., Mutsaers, A. J., Dumont, D. J., & Kerbel, R. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3217 · Cited by 114
Donners, M. M. P. C., Wolfs, I. M. J., Olieslagers, S., Mohammadi-Motahhari, Z., Tchaikovski, V., Heeneman, S., van Buul, J. D., Caolo, V., Molin, D. G. M., Post, M. J., et al. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.213124 · Cited by 105
Angiogenic Functions of Voltage-gated Na+ Channels in Human Endothelial Cells
Andrikopoulos, P., Fraser, S. P., Patterson, L., Ahmad, Z., Burcu, H., Ottaviani, D., Diss, J. K. J., Box, C., Eccles, S. A., & Djamgoz, M. B. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.187559 · Cited by 123
VEGF and Intraocular Neovascularization: From Discovery to Therapy
Ferrara, N. (2016) · Translational Vision Science & Technology · doi:10.1167/tvst.5.2.10 · Cited by 114
“Direct effects of VEGF or PlGF on NRP1, independent of VEGF receptor activation, also have been reported.(68) In”
BackgroundLiu, N., Ding, D., Hao, W., Yang, F., Wu, X., Wang, M., Xu, X., Ju, Z., Liu, J., Song, Z., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw549 · Cited by 115
“Endothelial cell migration is a key step in angiogenesis (26).”
BackgroundRspo1/Wnt signaling promotes angiogenesis via Vegfc/Vegfr3
Gore, A. V., Swift, M. R., Cha, Y. R., Lo, B. D., McKinney, M. C., Li, W., Castranova, D., Davis, A. E. M., Mukouyama, Y., & Weinstein, B. M. (2011) · Development · doi:10.1242/dev.068460 · Cited by 120
“VEGF signaling plays a well-documented central role in the vasculature, regulating endothelial specification, differentiation, migration and survival during angiogenesis and lymphangiogenesis (Olsson et al., 2006).”
BackgroundMellberg, S., Dimberg, A., Bahram, F., Hayashi, M., Rennel, E., Ameur, A., Westholm, J. O., Larsson, E., Lindahl, P., Cross, M. J., et al. (2009) · The FASEB Journal · doi:10.1096/fj.08-123810 · Cited by 124
“VEGFR1 is expressed on hematopoietic and vascular endothelial cells, whereas VEGFR2 is preferentially expressed on vascular endothelial cells (2).”
BackgroundSelf-citationGrowth factors in ischemic stroke
Lanfranconi, S., Locatelli, F., Corti, S. P., Candelise, L., Comi, G. P., Baron, P., Strazzer, S., Bresolin, N., & Bersano, A. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00987.x · Cited by 119
“VEGF’s biological functions are mediated by its binding to receptors on vascular and lymph-vessel endothelial cells as well as on other cell types including fibroblasts, smooth muscle cells, haematopoietic stem cells, epithelial cells, monocytes and macrophages [178].”
BackgroundIntegration of pro- and anti-angiogenic signals by endothelial cells
Kazerounian, S., & Lawler, J. (2017) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-017-0433-3 · Cited by 123
VEGF-B Promotes Endocardium-Derived Coronary Vessel Development and Cardiac Regeneration
Ramste, M. O., Sultan, I., Paech, J., Hemanthakumar, K. A., Yu, W., He, L., Tang, J., Sun, Y., Hlushchuk, R., Huan, X., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.050635 · Cited by 118
Endothelial epsin deficiency decreases tumor growth by enhancing VEGF signaling
Pasula, S., Cai, X., Dong, Y., Messa, M., McManus, J., Chang, B., Liu, X., Zhu, H., Mansat, R. S., Yoon, S.-J., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64537 · Cited by 114
Jana, S., Chatterjee, K., Ray, A. K., DasMahapatra, P., & Swarnakar, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163540 · Cited by 116
Beyond histones – the expanding roles of protein lysine methylation
Wu, Z., Connolly, J., & Biggar, K. K. (2017) · FEBS Journal · doi:10.1111/febs.14056 · Cited by 116
Angiogenesis and Anti-Angiogenic Therapy in Gastric Cancer
Nienhüser, H., & Schmidt, T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms19010043 · Cited by 113
“VEGF-A belongs to a family of cytokines including VEGF-B, -C, -D, -E and placental growth factor (PlGF) [25,26].”
BackgroundBiological aspects in controlling angiogenesis: current progress
Akbarian, M., Bertassoni, L. E., & Tayebi, L. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04348-5 · Cited by 127
“Signs of activation of high mitotic endothelial cells are an increase in the capacity for invasion and proteolysis of the extracellular matrix [11].”
BackgroundVasodilator factors in the systemic and local adaptations to pregnancy
Valdés, G., Kaufmann, P., Corthorn, J., Erices, R., Brosnihan, K. B., & Joyner, J. (2009) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-7-79 · Cited by 110
Cancer antineovascular therapy with liposome drug delivery systems targeted to BiP/GRP78
Katanasaka, Y., Ishii, T., Asai, T., Naitou, H., Maeda, N., Koizumi, F., Miyagawa, S., Ohashi, N., & Oku, N. (2010) · International Journal of Cancer · doi:10.1002/ijc.25276 · Cited by 110
“VEGF induces the phosphorylation of VEGFR tyrosine kinases, and thereby activates mitogen-activated protein kinase (MAPK) mediated by phospholipase C-c (PLCc) or the AKT/PKB signal cascade mediated by phosphatidylinositol-3 kinase (PI3K).(7)”
BackgroundMa, X., Li, Z., Li, T., Zhu, L., Li, Z., & Tian, N. (2017) · Europe PMC (PubMed Central) · Cited by 109
Effects of Low-Level Laser Therapy on Skeletal Muscle Repair: A Systematic Review
Alves, A. N., Fernandes, K. P. S., Deana, A. M., Bussadori, S. K., & Mesquita‐Ferrari, R. A. (2014) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000000158 · Cited by 123
“This process is regulated by vascular endothelial growth factor (VEGF), which exerts different effects on the vascular endothelium, including endothelial cell proliferation, the induction of rapid microvascular permeability, the survival of endothelial cells, the migration and adhesion of endothelial cells, and subseq…”
BackgroundLymphatic vessels develop during tubulointerstitial fibrosis
Sakamoto, I., Ito, Y., Mizuno, M., Suzuki, Y., Sawai, A., Tanaka, A., Maruyama, S., Takei, Y., Yuzawa, Y., & Matsuo, S. (2009) · Kidney International · doi:10.1038/ki.2008.661 · Cited by 109
Saraswati, S., Kanaujia, P. K., Kumar, S., Kumar, R., & Alhaider, A. A. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-82 · Cited by 112
“Autophosphorylation of Tyr1175 on VEGFR2 is crucial for endothelial cell proliferation, and leads to the activation of downstream signaling events including Src family kinase [5], focal adhesion kinase (FAK) [6,7], phosphoinisitide 3 kinase/AKT kinase, Mammalian target of rapamycin (mTOR) [8], protein kinase C/protein…”
BackgroundResultInfluentialNanocomposites as biomolecules delivery agents in nanomedicine
Bamburowicz‐Klimkowska, M., Popławska, M., & Grudziński, I. P. (2019) · Journal of Nanobiotechnology · doi:10.1186/s12951-019-0479-x · Cited by 111
The Role of YAP and TAZ in Angiogenesis and Vascular Mimicry
Azad, T., Ghahremani, M., & Yang, X. (2019) · Cells · doi:10.3390/cells8050407 · Cited by 116
“PLGF and VEGFB just bind VEGFR-1.”
BackgroundBonner, J. S., Lantier, L., Hasenour, C. M., James, F. D., Bracy, D. P., & Wasserman, D. H. (2013) · Diabetes · doi:10.2337/db12-0354 · Cited by 107
“In particular, VEGF-A stimulates the formation of new vascular networks by recruiting and differentiating endothelial progenitor cells in addition to inducing endothelial cell proliferation and migration (24).”
BackgroundChen, H., Cong, Q., Du, Z., Liao, W., Zhang, L., Yao, Y., & Ding, K. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.08.020 · Cited by 111
Xu, M., & Yadavalli, V. K. (2019) · ACS Sensors · doi:10.1021/acssensors.9b00230 · Cited by 110
Bai, Y., Bai, X., Wang, Z., Zhang, X., Ruan, C., & Miao, J. (2011) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2011.04.016 · Cited by 113
“At the post-transcriptional regulation level to these angiogenic stimulators, in addition to the regulations by many up-stream factors (Ferrara et al., 2003; Olsson et al., 2006), the regulation by miRNAs is being considered asoneof themost important regulators.”
BackgroundKitazume, S., Imamaki, R., Ogawa, K., Komi, Y., Futakawa, S., Kojima, S., Hashimoto, Y., Marth, J. D., Paulson, J. C., & Taniguchi, N. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.073106 · Cited by 111
White, M. P., Rufaihah, A. J., Liu, L., Ghebremariam, Y. T., Ivey, K. N., Cooke, J. P., & Srivastava, D. (2013) · Stem Cells · doi:10.1002/stem.1267 · Cited by 106
The Role of Macrophages in Vascular Repair and Regeneration after Ischemic Injury
Hong, H., & Tian, X. Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176328 · Cited by 113
“VEGF-VEGFR Activate NOTCH signaling, induce maturation and M2 polarization Promote EC migration, proliferation and angiogenesis [19,27]”
BackgroundLi, M., Xu, Z., Zhang, L., Cui, M., Zhu, M., Guo, Y., Sun, R., Han, J., Song, E., He, Y., et al. (2021) · ACS Nano · doi:10.1021/acsnano.1c00680 · Cited by 107
Huang, W., Wu, H., Li, D., Song, J., Xiao, Y., Liu, C., Zhou, J., & Sui, Z. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b06135 · Cited by 114
VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS
RANDI, A. M., Laffan, M., & Starke, R. D. (2013) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2013.060 · Cited by 116
Zaytseva, Y. Y., Elliott, V. A., Rychahou, P., Mustain, W. C., Kim, J. T., Valentino, J., Gao, T., O’Connor, K. L., Neltner, J. M., Lee, E. Y., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu042 · Cited by 104
“Despite multiple preclinical studies demonstrating the relevance of inhibition of VEGF signal transduction pathways (15), the clinical benefit of anti-VEGF therapy is limited due to acquired resistance (16).”
BackgroundManickam, V., Tiwari, A., Jung, J.-J., Bhattacharya, R., Goel, A., Mukhopadhyay, D., & Choudhury, A. (2010) · Blood · doi:10.1182/blood-2010-06-291690 · Cited by 111
Eldehna, W. M., Abou‐Seri, S. M., Kerdawy, A. M. E., Ayyad, R. R. A., Hamdy, A. M., Ghabbour, H. A., Ali, M. M., & Ella, D. A. A. E. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.02.029 · Cited by 104
Anticarcinogenic Effects of α-Mangostin: A Review
Zhang, K., Gu, Q., Yang, K., Ming, X., & Wang, J. (2016) · Planta Medica · doi:10.1055/s-0042-119651 · Cited by 122
“This binding causes conformational changes of the receptors, followed by dimerization and autophosphorylation of the tyrosine residues, thereby activating downstream signaling, such as MAPK and PI3K/Akt pathways [99].”
BackgroundPatterned cell and matrix dynamics in branching morphogenesis
Wang, S., Sekiguchi, R., Daley, W. P., & Yamada, K. M. (2017) · Journal of Cell Biology · doi:10.1083/jcb.201610048 · Cited by 105
“The regulation and cross talk of these pathways has been reviewed extensively (Hennighausen and Robinson, 2005; Costantini and Shakya, 2006; Olsson et al., 2006; Patel et al., 2006; Jørgensen et al., 2007; Lu and Werb, 2008; Affolter et al., 2009; Costantini and Kopan, 2010; Blake and Rosenblum, 2014).”
BackgroundDellinger, M. T., & Brekken, R. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028947 · Cited by 103
“There is growing evidence that vascular endothelial growth factor-A (VEGF-A), a ligand of the receptor tyrosine kinases VEGFR1 and VEGFR2, promotes lymphangiogenesis.”
BackgroundInfluentialCancer of the Pancreas: Molecular Pathways and Current Advancement in Treatment
Polireddy, K., & Chen, Q. (2016) · Journal of Cancer · doi:10.7150/jca.14922 · Cited by 119
“It promotes endothelial cell proliferation and survival by binding to its receptors VEGFR-1 and VEGFR-2 (36).”
BackgroundVEGF-Directed Blood Vessel Patterning: From Cells to Organism
Bautch, V. L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006452 · Cited by 99
Federico, A. D., Rizzo, A., Carloni, R., Giglio, A. D., Bruno, R., Ricci, D., & Brandi, G. (2021) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2022.2009455 · Cited by 105
Yang, Y., Xie, P., Opatowsky, Y., & Schlessinger, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914052107 · Cited by 102
“V endothelial growth factors (VEGFs) regulate blood and lymphatic vessel development and homeostasis by binding to and activating the three members of the VEGF-receptor (VEGFR) family of receptor tyrosine kinases (RTKs) (1).”
BackgroundSignal transduction induced in endothelial cells by growth factor receptors involved in angiogenesis
Schweighofer, B., & Hofer, E. (2007) · Thrombosis and Haemostasis · doi:10.1160/th06-08-0470 · Cited by 115
“Neuropilins, although they lack intrinsic catalytic activity, appear to enhance signaling and biological responses to VEGF receptors and may be required for certain functions such as the organization of endothelial cells into 3-dimensional vessel structures (74).”
Huynh, D. L., Sharma, N., Singh, A. K., Sodhi, S. S., Zhang, J., Mongre, R. K., Ghosh, M., Kim, N., Park, Y. H., & Jeong, D. K. (2017) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(17)30005-5 · Cited by 111
“Thus, inhibition of VEGF/VEGFR is one of the molecular targets in anti-tumor strategies ([58-60]).”
BackgroundExosomes: Mediators of bone diseases, protection, and therapeutics potential
Behera, J., & Tyagi, N. (2018) · Oncoscience · doi:10.18632/oncoscience.421 · Cited by 101
“(2010), reported that exosomes derived from MSCs contain miRNAs, including miR210, miR126, miR132, and miR21, which are shown to be involved in angiogenesis [106] and miR-6087 which”
BackgroundFluctuating Roles of Matrix Metalloproteinase‐9 in Oral Squamous Cell Carcinoma
Vilén, S., Salo, T. A., Sorsa, T. A., & Nyberg, P. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/920595 · Cited by 111
Molecular differentiation and specialization of vascular beds
Rocha, S. F., & Adams, R. H. (2009) · Angiogenesis · doi:10.1007/s10456-009-9132-x · Cited by 97
“The VEGF pathway is critical for blood vessel formation, given its participation in a variety of vascular processes including EC proliferation, migration, survival, and arterial–venous cell fate specification [49, 50].”
BackgroundChemomechanical mapping of ligand–receptor binding kinetics on cells
Lee, S., Mandic, J., & Vliet, K. J. V. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702668104 · Cited by 101
Metadata
- Authors
- Olsson, A.-K., Dimberg, A., Kreuger, J., & Claesson-Welsh, L.
- Affiliations
- Uppsala University (SE)
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2006-05
- Volume
- 7
- Issue
- 5
- Pages
- 359-371
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2091774189
- Cited by
- 3,122
- References
- 141
- Citations by year
- 2026: 88 · 2025: 107 · 2024: 116 · 2023: 127 · 2022: 127 · 2021: 158 · 2020: 160 · 2019: 156 · 2018: 156 · 2017: 176 · 2016: 202 · 2015: 184 · 2014: 212 · 2013: 231 · 2012: 190
- FWCI
- 10.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Vetenskapsrådet
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Axon Guidance and Neuronal Signaling
- Keywords
- VEGF receptors, VEGF signaling, VEGFR1, VEGFR2, VEGFR-3, angiogenesis, pathological angiogenesis, vascular development, endothelial cells, signal transduction, anti-angiogenic cancer therapy
- MeSH terms
- Animals, Humans, Stem Cells, Signal Transduction, Neovascularization, Physiologic, Receptors, Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factors, Embryonic Development
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.